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Integrated Human System Risk Management
Structure
– HQ - Office of the Chief Health and Medical 
Officer (OCHMO) – Health and Medical 
Authority (HMTA) – Level I 
• Medical Policy, Health and Performance Standards, 
and Bioethics
• Risk Assessment and Mitigation - via the JSC Chief 
Medical Officer (JSC CMO) – Level II
- Crew Health and Safety (CHS) 
• Medical Operations & Occupational Health (career 
health care/post career monitoring)
- Human Research Program (HRP) 
- Perform scientific research necessary to 
understand & reduce health & performance 
risks for space exploration
- AES & STMD – Technology/Protocol Development 
– International Space Station (ISS), Orion, 
Commercial Crew Programs
• Implementation of Medical Operations
– Medical Requirements, Tests and hardware
OCHMO
HMTA via 
HSRB
Policy, Operations, and Research  Human Health/Performance Risk Framework
Standards/Risks
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Risk Assessment & Mitigation
Crew Health & Safety
Human Research Program 
Space Biology
CASIS
AES
STMD
Terrestrial – Government, Private
Program Requirements/ 
Countermeasure Implementation
ISS
CCP
MPCV/Orion
National Aeronautics and Space Administration
Hostile 
Spaceflight 
Environment
Altered Gravity
Radiation
Isolation
Hostile/Closed Environmt.
Distance from Earth Mitigations
NASA Human Health and Performance
Goal: Enable Successful Space Exploration by Minimizing the Risks of Spaceflight 
Hazards
Deliverables:
Technologies
Countermeasures
(prevention & treatment)
Spaceflight/Design Reference Missions 
Hazards
Risks
Standards
Evidence
Human Risks
Bone & Muscle 
loss, Radiation 
Exposure, Toxic 
Exposure, etc.
Medical Ops 
Occupational 
Surveillance
Environmental
Research
Standards to
Requirements
4Design Reference Missions (DRMs) Categories
All of the Human System Risks are evaluated against the following DRMs:
DRM Categories Mission 
Duration
Gravity 
Environment
Radiation
Environment
Earth Return
Low Earth Orbit 6 months Microgravity LEO - Van Allen 1 day or less
1 year Microgravity LEO - Van Allen 1 day or less
Deep Space Sortie 1 month Microgravity Deep Space < 5 days
Lunar Visit/Habitation 1 year 1/6g Lunar 5 Days
Deep Space Journey/ 
Habitation
1 year Microgravity Deep Space Weeks to 
Months
Planetary Visit/Habitation 3 years Fractional/
Microgravity
Planetary* Months
Examples of Missions that would fall into the DRM Categories:
Low Earth Orbit – ISS6, ISS12, Commercial Suborbital, Commercial Visits to ISS, future commercial platforms in LEO
Deep Space Sortie:  MPCV test flights, moon fly around or landing, visits to L1/L2, deep space excursion
Lunar Habitation:  Staying on the surface more than 30 Days  (less than 30 days would be similar)
Deep Space Habitation:  L1/L2 Habitation, Asteroid visit, journey to planets
Planetary Habitation:  Living on a planetary surface, MARs & extended journey in microgravity to and from
*Planet has no magnetic poles, limited atmosphere 
Hazards of Spaceflight
Hazards Drive Human Spaceflight Risks
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Altered Gravity -
Physiological Changes
Distance from Earth 
Hostile/
Closed Environment
Space Radiation
Isolation & Confinement
Acute In-flight effects
Long term cancer risk
Balance Disorders
Fluid Shifts
Cardiovascular Deconditioning
Muscle Atrophy
Bone Loss
Drives the need for additional 
“autonomous” medical care 
capacity – cannot come home for 
treatment
Behavioral aspect of isolation
Sleep disorders
Vehicle Design
Environmental – CO2 Levels, 
Toxic Exposures, Water, Food
Decreased Immune Function
Evidence is gathered from in-flight medical and research operations, spaceflight analogs, 
terrestrial analogs, and/or animal data. Data must be correlated from NASA medical 
(LSAH), research (LSDA), environmental & terrestrial data bases.
NASA/HMTA Human Risks Evidence Base
Medical Data (mandatory)
Medical data generally does not 
require informed consent and 
may only be used for:
 Medical care by clinician
 Occupational Surveillance
Research Data (voluntary)
• Research data requires 
informed consent by the 
subject & the data.
• Ground analogs
• Includes animal research
Environmental & 
Operational Data
Generation of Metrics to assess Human System Risks
Data gathered to understand the 
occupational  environment, such 
as: 
• CO2 levels, acoustic, landing 
loads, radiations levels, mission 
operations
HMTA Human System Risk Assessment
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Related terrestrial 
incidence, treatment 
and research
Terrestrial Data
+¾ of Risk Evidence from Operational 
Medical/Environmental/ Occupational 
Surveillance Programs
¼ of Risk Evidence from 
Research Programs (Focus on 
Human System Risks understanding and 
countermeasure development)Correlation of data by 
subject matter experts 
& physicians.
Summary of Human Risks of Spaceflight
Grouped by Hazards – 30 Human Risks
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Altered Gravity Field
1. Spaceflight-Induced Intracranial 
Hypertension/Vision Alterations
2. Renal Stone Formation 
3. Impaired Control of 
Spacecraft/Associated Systems and 
Decreased Mobility Due to 
Vestibular/Sensorimotor Alterations 
Associated with Space Flight
4. Bone Fracture due to spaceflight 
Induced changes to bone
5. Impaired Performance Due to Reduced 
Muscle Mass, Strength & Endurance
6. Reduced Physical Performance 
Capabilities Due to Reduced Aerobic 
Capacity 
7. Adverse Health Effects Due to Host-
Microorganism Interactions
8. Urinary Retention
9. Orthostatic Intolerance During Re-
Exposure to Gravity
10.Cardiac Rhythm Problems
11.Space Adaptation Back Pain
Radiation
1. Space Radiation Exposure 
on Human Health (cancer, 
cardio and CNS)
Isolation
1. Adverse Cognitive or 
Behavioral Conditions & 
Psychiatric Disorders 
2. Performance & Behavioral 
health Decrements Due to 
Inadequate Cooperation, 
Coordination, 
Communication, & 
Psychosocial Adaptation 
within a Team
Hostile/Closed Environment-
Spacecraft Design
1. Acute and Chronic Carbon Dioxide Exposure
2. Performance decrement and crew illness due 
to inadequate food and nutrition
3. Reduced Crew Performance and of Injury Due 
to Inadequate Human-System Interaction 
Design (HSID)
4. Injury from Dynamic Loads
5. Injury and Compromised Performance due to 
EVA Operations
6. Adverse Health & Performance Effects of 
Celestial Dust Exposure
7. Adverse Health Event Due to Altered Immune 
Response
8. Reduced  Crew Health and Performance Due 
to Hypobaric Hypoxia
9. Performance Decrements & Adverse Health 
Outcomes Resulting from Sleep Loss, 
Circadian Desynchronization, & Work 
Overload
10. Decompression Sickness
11. Toxic Exposure
12. Hearing Loss Related to Spaceflight
13. Injury from Sunlight Exposure
14. Crew Health Due to Electrical Shock
Distance from Earth
1. Adverse Health Outcomes 
& Decrements in 
Performance due to 
inflight Medical 
Conditions 
2. Ineffective or Toxic 
Medications due to Long 
Term Storage
Concerns
1. Clinically Relevant Unpredicted Effects of Meds
2. Intervertebral Disc Damage upon & 
immediately after re-exposure to Gravity
Factors that Influence Human Risk – by Mission Phase
Pre - Mission Post - MissionIn - Mission
Generic Factors
Screening Criteria
Pre-flight treatment(s)
Pre-flight training
Flight Assignments
-Age, sex, physiological
Generic Factors
Mission Duration
Mission location
-LEO, BLEO
Countermeasures
Generic Factors
Reconditioning
Post mission Screening
Occupational Health 
Care for Astronauts
Duty/lifestyle constraints
Treatments
Determines/Reduces 
Total Risk Posture
*In development *In development 
HMTA considers pre, in and post mission factors/countermeasures to evaluate 
risks and ensure crew health.
Radiation Example
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Radiation Factors
Shielding
Mission Duration
LEO vs. BLEO
Solar Min vs. Max
Operational Planning
Risk Assessment
- Dosimetry
Radiation Factors
Personalized Cancer Screening*
Cancer Treatment
Radiation Factors
Individual Sensitivity – Biomarkers* 
Selection – age, sex
Model Projection of Risk
9Sample Risk – Human System Risk Board (HSRB)
Assessment Performed for all 30 Risks
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Sample Risk – Human System Risk Board (HSRB)
Assessment Performed for all 30 Risks
Metric for Risk of Impaired Performance Due to Reduced Muscle 
Mass, Strength & Endurance
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% Crew that do NOT meet Health and Fitness Muscle Standard 
< 20% loss of pre-flight baseline
Knee Flex Strength
ISS
6 months
N=22
ISS
6 months
N=5
ISS
12 months
N=?
TBD
50%
100%
36%
20%
25%
ISS
6 months
N=25
SPRINT Study – Standardized, 
tracked prescriptions
Countermeasure(s) iRED
TVIS, CEVIS
Non-Standard*
Exercise 
Prescription
ARED
T2, CEVIS
Non-Standard* 
Exercise 
Prescription
ARED
T2, CEVIS
SPRINT Research 
Exercise Prescription
ARED
T2, CEVIS
Non-Standard*
Exercise 
Prescription
Data based on LSAH/Exercise Lab data assessment, MRIDs and Sprint Research Data 7/2013
(*) “Non-Standard” indicates customized exercise prescriptions
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= Risk Evaluation 
Assessment
Sample Risk – Human System Risk Board (HSRB)
Assessment Performed for all 30 Risks
Deliverables Required Responsible
Program/Mechanism
Budget ($M) - FY
(2014-2018)/Timeline
Knowledge/Research:
-ARED Kinematics
-ISS SPRINT
-Other Rsch Tasks (Active/Planned)
Technology:
-Portable Load Sensing Evals.
-Adv. Exercise Concept Evals. ISS
-MPCV Exercise Concept Dev.
- Adv Exercise Risk Mitigation
Operational Protocols:
-ASCR Std - Exercise Prescriptions
-MedB 5.1-3 (Fn Fit., IsoTestingCMS)
-ISS Ex. HW – Sustaining, Log, Main.
Guidelines/Requirements/Standards:
-Standard Updates
-Requirements for MPCV
HRP
HRP
HRP/NSBRI
HRP/ISS/EA
HRP
HRP
TBD
ISS/CHS
ISS
ISS
ISS/CHS/HRP
MPCV/CHS/HRP
$0.5M
$3M
$8M
$600K/2015
$6.3M
$1.5M
~$7M
$4M
$3.3M
$27M
$0.2M/2015
$0.1M/2014
$19.5M
Countermeasure 
implementation
Countermeasure 
Optimization
Mars Concept 
Devices
*Italics indicates desired work for which a Program sponsor has not been identified (not 
included in totals)
Note: All tasks costs are shared with the Aerobic  risk except for MedB5.1-3
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CHS
ISS
HRP
FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 FY21
Force Shoe Demo
Adv. Ex. HW Dev.
Int. Muscle CMs
ISS Ops – pre, in & post flight
SPRINT 
Occ. Surveillance and Reconditioning
MissionTask Evals. ARED Kine.
Total Budget 2014-18 = $54M
Each risk matures as it 
follows the CRM Process
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Risks to Standard - Requirement Flow
13
Human Risks Disposition for all DRMs
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A – Accepted   RM- Requires Mitigation Green  – low/very low consequence         Yellow  – low to medium consequence     Red – high consequenceeYellowGre n
4/22/2015
Human System Risks 04/22/15
Low Earth 
Orbit 
Low Earth 
Orbit
Deep Space 
Sortie
Lunar 
Visit/Habitation
Deep Space 
Journey/Habit
ation
Planetary Low Earth Orbit Low Earth Orbit
Deep Space 
Sortie
Lunar 
Visit/Habitation
Deep Space 
Journey/ 
Habitation
Planetary 
6 Months 12 Months 30 Days 1 year 1 Year 3 years 6 Months 12 Months 30 Days 1 year 1 Year 3 years
VIIP A A A A RM RM A A A A RM RM
Renal Stone Formation A A A A RM RM RM RM RM RM RM RM
Inadequate food and nutrition A A A A A RM A A A A A RM
Risk of Space Radiation Exposure A A A A A TBD A A A RM RM RM
Medications Long Term Storage A A A A A RM A A A A A RM
Acute and Chronic Carbon Dioxide A A A A RM RM A A A A A A
Inflight Medical Conditions   A A A RM RM RM A A A RM RM RM
Cognitive or Behavioral Conditions A RM A RM RM RM A A A A A RM
Risk of Bone Fracture A A A A A RM A A A A A A
Human-System Interaction Design A A A RM RM RM A A A A A A
 Team Performance Decrements  A A A A RM RM A A A A A A
Cardiac Rhythm Problems- Under Review A A A A RM RM A A A A A A
Reduced Muscle Mass, Strength A A A A A RM A A A A A RM
Reduced Aerobic Capacity A A A A A RM A A A A A RM
Sensorimotor Alterations  A A A RM RM RM A A A A A RM
Injury from Dynamic Loads A A RM RM RM RM A A RM RM RM RM
Sleep Loss A A A A RM RM A A A A RM RM
Altered Immune Response A A A A A RM A A A A A RM
Celestial Dust Exposure N/A N/A TBD A TBD TBD N/A N/A TBD A TBD TBD
Host-Microorganism Interactions A A A A A RM A A A A A RM
Injury due to EVA Operations A A A RM A RM A A A RM  A RM
Decompression Sickness A A RM A RM A A A A RM A RM
Toxic Exposure A A A A A A A A A A A A
 Hypobaric Hypoxia
 RM RM A RM RM RM RM RM A RM RM RM
Space Adaptation Back Pain A A A A A A N/A N/A N/A N/A N/A N/A
Urinary Retention A A A A A A A A A A A A
Hearing Loss Related to Spaceflight A A A A A A A A A A A A
Orthostatic Intolerance A A A A A A A A A A A A
Injury from Sunlight Exposure A A A A A A A A A A A A
Risk of electrical shock A A A A A A A A A A A A
In Mission Risk - Operations Post Mission Risk - Long Term Health
Summary
• Human Health/Performance Risk Framework – Level I (Policy) & Level II 
(Operations & Research)
• Risk Assessments for Space Exploration are based on DRM 
Categories as actual DRMs are not available (conceptual) – These 
categories were designed to envelope the different DRMs
• 5 hazards of Spaceflight engender the 30 identified HS risks
• All factors that influence human risk pre/in/post-flight are evaluated 
together to ensure crew health
• Systematic development of individual risk crew summaries with risk 
statements, hazards, state of knowledge, metrics, LxC ratings, deliverables, 
etc. evolve via the Continuous Risk Management (CRM) process
• The individual risk plans are “Projectized” via high-level budget pie 
charts and high-level schedules via Gantt charts
• Portfolio Management approach will take advantage of risk dispositions 
and common elements identified within individual risks to develop 
priorities and broad range mitigation strategies 
Thank you!
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Human Risks
Backup
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